Nu Skin Enterprises (NYSE:NUS – Get Free Report) is scheduled to announce its earnings results after the market closes on Thursday, November 7th. Analysts expect the company to announce earnings of $0.20 per share for the quarter. Nu Skin Enterprises has set its FY24 guidance at $0.75-0.95 EPS and its Q3 guidance at $0.08-0.18 EPS.Investors that are interested in registering for the company’s conference call can do so using this link.
Nu Skin Enterprises (NYSE:NUS – Get Free Report) last announced its earnings results on Thursday, August 8th. The company reported $0.21 EPS for the quarter, beating the consensus estimate of $0.17 by $0.04. The company had revenue of $439.10 million during the quarter, compared to the consensus estimate of $431.87 million. Nu Skin Enterprises had a negative net margin of 8.05% and a positive return on equity of 7.80%. The firm’s revenue for the quarter was down 12.2% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.54 earnings per share. On average, analysts expect Nu Skin Enterprises to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Nu Skin Enterprises Stock Performance
Shares of NUS stock opened at $6.34 on Tuesday. The firm has a 50-day moving average of $7.06 and a 200-day moving average of $10.03. The company has a market cap of $315.11 million, a P/E ratio of -2.13 and a beta of 1.14. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.12 and a quick ratio of 1.33. Nu Skin Enterprises has a one year low of $5.95 and a one year high of $20.75.
Nu Skin Enterprises Dividend Announcement
Analyst Upgrades and Downgrades
Several equities analysts recently weighed in on the stock. DA Davidson reduced their price target on shares of Nu Skin Enterprises from $12.50 to $11.00 and set a “neutral” rating for the company in a research report on Monday, August 12th. StockNews.com lowered shares of Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research report on Wednesday, October 23rd. Finally, Citigroup reduced their price target on shares of Nu Skin Enterprises from $11.50 to $6.75 and set a “neutral” rating for the company in a research report on Tuesday, October 22nd.
Check Out Our Latest Report on Nu Skin Enterprises
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Further Reading
- Five stocks we like better than Nu Skin Enterprises
- What Are Dividend Achievers? An Introduction
- Intel: Is Now the Time to Be Brave?Â
- 3 Warren Buffett Stocks to Buy Now
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Roth IRA Calculator: Calculate Your Potential Returns
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.